% (n) | |
---|---|
Total patients | 100 (n = 120) |
Males | 84.2 (n = 101) |
Females | 15.8 (n = 19) |
Age (in years) | |
Range | 24–81 |
Mean | 55.91 |
Standard deviation | 11.706 |
18–24 years | 0.8 (n = 1) |
25–44 years | 16.7 (n = 20) |
45–60 years | 45 (n = 54) |
61–75 years | 35 (n = 42) |
76–90 years | 2.5 (n = 3) |
Occupation | |
Skilled | 5.8 (n = 7) |
Unskilled | 65.8 (n = 79) |
Unemployed | 28.4 (n = 34) |
Comorbidity | |
No comorbidity | 60.0 (n = 72) |
Single comorbidity | 21.7 (n = 26) |
Multimorbidity | 18.3 (n = 22) |
Head and neck cancer diagnosis site | |
Oral cavity | 64.1 (n = 77) |
Oropharynx | 11.7 (n = 14) |
Hypopharynx | 10.0 (n = 12) |
Larynx | 12.5 (n = 15) |
Others (nasopharynx/paranasal sinus/salivary glands) | 1.7 (n = 2) |
Stage of malignancy | |
Non-metastatic | 94.2 (n = 113) |
Metastatic | 5.8 (n = 7) |
Treatment received | |
Surgery | 4.2 (n = 5) |
Surgery + Adjuvant treatment (RT/CTRT) | 57.5 (n = 69) |
Definitive treatment (RT/CTRT) | 37.5 (n = 45) |
Palliative RT | 0.8 (n = 1) |
Dose of CTRT | n = 56 |
70 Gy/35# | 57.1 (n = 32) |
66 Gy/30# | 3.6 (n = 2) |
66 Gy/33# | 26.8 (n = 15) |
Others | 12.5 (n = 7) |
Dose of RT | n = 59 |
70 Gy/35# | 15.3 (n = 9) |
60 Gy/30# | 78.0 (n = 46) |
66 Gy/33# | 5.1 (n = 3) |
22.5 Gy/5# | 1.7 (n = 1) |
Post-treatment period (months) | |
3–12 | 58.3 (n = 78) |
13–36 | 29.2 (n = 35) |
> 36 | 12.5 (n = 15) |